Bausch Health Cos
Bausch Health Companies Inc., commonly referred to as Bausch Health, is a prominent global healthcare company headquartered in Laval, Quebec, Canada. Founded in 2013, the company has rapidly established itself in the pharmaceutical and medical device industries, focusing on eye health, dermatology, and gastrointestinal disorders. Bausch Health's diverse portfolio includes innovative products such as contact lenses, ocular pharmaceuticals, and dermatological treatments, distinguished by their commitment to quality and patient care. The company has achieved significant milestones, including the expansion of its product offerings and strategic acquisitions that enhance its market position. With a strong presence in North America, Europe, and other regions, Bausch Health continues to be recognised for its dedication to improving patient outcomes and advancing healthcare solutions worldwide.
DitchCarbon Score
How does Bausch Health Cos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Instruments industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bausch Health Cos's score of 34 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bausch Health Cos's reported carbon emissions
In 2023, Bausch Health Cos reported total carbon emissions of approximately 49.9 million tonnes CO2e from Scope 1 and 65.5 million tonnes CO2e from Scope 2. The company's Scope 3 emissions included about 11.5 million tonnes CO2e from capital goods, 38 million tonnes CO2e from purchased goods and services, 5.4 million tonnes CO2e from waste generated in operations, and 3.2 million tonnes CO2e from fuel and energy-related activities. In 2022, Bausch Health's emissions were slightly lower, with Scope 1 emissions at about 46.7 million tonnes CO2e and Scope 2 emissions at 64.8 million tonnes CO2e. The total emissions from Scope 1 and 2 combined reached approximately 106.7 million tonnes CO2e. While specific reduction targets were not detailed, Bausch Health has engaged with the Carbon Disclosure Project (CDP) and received a score of "D" in 2023, indicating a need for improvement in their climate strategy. The company is actively working towards enhancing its sustainability practices, although no formal science-based targets or significant reduction initiatives have been publicly disclosed.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2022 | 2023 | |
|---|---|---|
| Scope 1 | 46,686,000 | 00,000,000 |
| Scope 2 | 50,513,000 | 00,000,000 |
| Scope 3 | 59,779,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bausch Health Cos is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
